Alcami Announces Manufacturing Agreement for Solasia’s API Darinaparsin
Alcami announces that it has finalized manufacturing and quality agreements with Solasia Pharma, K.K. (TSE: 4597) for the clinical supply manufacture of the active pharmaceutical…
Read More...
Read More...
